RNA Therapy Helped Preserve Muscle During Weight Loss
A new experimental approach may assist in protecting muscle mass while enhancing fat loss during weight management treatments.
Updated on Sept. 21, 2026 in Weight Loss
Live Poll
Should future weight-loss medications prioritize preserving muscle mass over total weight reduction?
Researchers have developed an experimental RNA therapy that, when paired with semaglutide, doubled fat loss compared to the drug alone while better preserving muscle mass in a mouse model. While these results are preliminary, they offer a potential strategy for improving weight loss outcomes.
Why it matters
GLP-1 receptor agonists like semaglutide are effective for weight loss but often cause loss of lean muscle mass, which is a concern for long-term metabolic health. This therapy aims to mitigate that side effect while simultaneously boosting the body's ability to burn fat.
In a preclinical study published in PNAS, mice receiving an RNA therapy alongside semaglutide saw a 5.5% reduction in lean mass compared to 10% with semaglutide alone, alongside a 50% reduction in body fat. Because these findings are restricted to mice, the results remain preliminary.
The players
Northwestern University Feinberg School of Medicine
An academic medical research institution that led the development and testing of the RNA therapy.
The details
The experimental therapy uses short RNA strands to inhibit a gene called ZFP423, which helps regulate how fat cells function. By inhibiting this gene, the treatment induces thermogenesis, encouraging white fat to convert into energy-burning beige fat. This process enhances the metabolic effects of semaglutide, potentially leading to improved glucose tolerance and better body composition outcomes.
Timeline
September 21, 2026: The study results were published in the journal Proceedings of the National Academy of Sciences.
Health Landscape
This research addresses the well-documented challenge of lean mass loss during treatment with GLP-1 receptor agonists. It marks an early step in evolving weight-management science beyond simple fat reduction toward maintaining metabolic tissue health.
Because this research is in the early stages and only tested in mice, it is not currently an available clinical treatment. If you are concerned about muscle mass changes while on weight loss medication, it is worth discussing appropriate resistance training or protein intake with your doctor.
The takeaway
This study highlights an emerging focus on preserving muscle tissue during significant weight reduction. Individuals managing their weight should prioritize conversations with their healthcare provider about maintaining lean muscle through nutrition and exercise as a foundation of care.
Further reading
For more on the current clinical standards for managing body composition, visit Weight Loss.
Live Poll
Should future weight-loss medications prioritize preserving muscle mass over total weight reduction?
